Drug Discovery
Betsy Baer of Waters Corporation shares her thoughts on solutions to various challenges in the pharma industry, and likely trends going forward
| 3 min read
New tech promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials—and to maximize their chances of success
| 4 min read
Virtual screening of 6,218 drugs and cell-based assays identifies best therapeutic medication candidates
| 2 min read
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges
| 2 min read
Industry-approved fluidic-free standard for label-free molecular interaction analysis
| 1 min read
New applications also provide a boost for the technique's possible use in subcellular characterization
| 4 min read
Demonstrating the novel technique on prexersatib, research team achieves a fully automated six-step synthesis with 65 percent isolated yield within 32 hours
| 3 min read
Understanding your digital integration requirements
| 1 min read
Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases
| 2 min read
